InvestSMART

Oneview Healthcare Plc (ASX:ONE)

ALERT: Price-sensitive ASX Announcement for ONE
Current share price for ONE : $0.195 0.01 (5.41%)+
Release
16 Apr 2026 4:35PM
Price at Release
$0.185
Full Release
download
Summary
Oneview Healthcare PLC, a global healthcare technology company, announced the results of its security purchase plan (SPP) which closed on April 10, 2026. Conducted alongside a A$19 million two-tranche placement, the SPP allowed eligible securityholders to apply for up to A$30,000 of new CHESS Depositary Interests at A$0.19 per CDI. The company received applications for 1,644,708 New CDIs, totaling approximately A$0.3 million, and all valid applications were accepted. Trading of the new CDIs will commence on April 20, 2026. Additionally, the second tranche of the Placement, expected to raise an additional A$7 million, will seek shareholder approval at the annual general meeting in September 2026. The funds are earmarked to bolster the company's balance sheet and facilitate the deployment of new technologies, including the AI-driven virtual patient assistant, Ovie.
Key Points
  • Oneview Healthcare PLC announced the results of its security purchase plan (SPP) that closed on April 10, 2026.
  • The SPP was conducted alongside an A$19 million two-tranche placement to institutional investors.
  • Eligible securityholders could apply for up to A$30,000 of new CHESS Depositary Interests at A$0.19 per CDI.
  • The company received applications for 1,644,708 New CDIs totaling approximately A$0.3 million.
  • All valid applications were accepted as the total applications were below the A$2 million offered amount.
  • The New CDIs will begin trading on ASX on April 20, 2026.
  • Tranche 2 of the Placement, expected to raise A$7 million, requires shareholder approval in September 2026.
  • Funds raised are intended to strengthen the balance sheet and support the deployment of new technologies.
  • MST Financial Services acted as the Lead Manager for the Placement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.